Eiger BioPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Moshe Arkin(10.09%)
Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(3.58%)
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ameriprise Financial, Inc.(0.00%),Columbia Management Investment Advisers, LLC(0.00%), etc.
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-683 Capital Management, LLC(4.7%),683 Capital Partners, LP(4.7%), etc.
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ameriprise Financial, Inc.(16.91%),Columbia Management Investment Advisers, LLC(16.06%), etc.
Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(10.09%)
Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Moshe Arkin(10.09%)
Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%), etc.
Eiger BioPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner KAYNE RICHARD A
Eiger BioPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner KAWAS LEEN
Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner KAYNE RICHARD A
Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner KAWAS LEEN
Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%), etc.
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Propel Bio Management LLC(10.9%),Leen Kawas(10.9%), etc.
Eiger BioPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Choong Ingrid
Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Choong Ingrid
Eiger BioPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Propel Bio Management, LLC(5.40%),Leen Kawas(5.40%)
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(2.1%)
Eiger BioPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-CEO Apelian David
Eiger BioPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-General Counsel Vollins James
No Data